Levoxigram

Levofloxacin, the active ingredient in Levoxigram, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections, including respiratory, urinary, and skin infections, and is prescribed for adult patients when indicated.

GNH USA supplies Levoxigram as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled manufacturing, regulatory compliance, and reliable global distribution. Our supply chain adheres to EU standards, providing consistent product availability for healthcare providers across multiple regions.

Levoxigram is a fluoroquinolone antibiotic indicated for several bacterial infections affecting different organ systems.

- Community‑acquired pneumonia: eradicates pathogenic bacteria in the lungs, improving respiratory function and reducing fever. - Acute bacterial sinusitis: clears sinus infection, relieving congestion, facial pain and discharge. - Acute exacerbations of chronic bronchitis: reduces bacterial load, aiding recovery of airway function. - Complicated urinary tract infections: eliminates uropathogens, helping restore normal urinary health. - Skin and soft‑tissue infections: treats bacterial cellulitis and wound infections, promoting healing.

Levofloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Rash: mild skin erythema. - Photosensitivity: increased sunburn risk.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, requiring immediate medical attention. - QT interval prolongation: may precipitate cardiac arrhythmias. - Severe hypersensitivity: including Stevens‑Johnson syndrome. - Central nervous system effects: seizures or psychosis. - Hepatotoxicity: elevated liver enzymes or jaundice. - Peripheral neuropathy: persistent numbness or tingling.

Before prescribing Levoxigram, clinicians should consider several safety factors.

- Assess renal function: dose adjustment may be required in impaired clearance. - Review cardiac history: avoid in patients with known QT prolongation. - Evaluate tendon health: contraindicated in patients with recent tendon injury or steroid use. - Monitor for hypersensitivity: discontinue at first sign of severe allergic reaction. - Caution in elderly: increased risk of CNS and tendon adverse events. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture and direct sunlight.

Levofloxacin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect, raising bleeding risk. - NSAIDs (e.g., ibuprofen): can heighten seizure potential. - Cyclosporine: increased risk of nephrotoxicity. - Theophylline: may raise plasma theophylline levels, causing toxicity.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., furosemide): may enhance QT prolongation. - Corticosteroids: combined use may increase tendon rupture risk. - Antidiabetic agents: monitor blood glucose as levofloxacin can affect glycemic control.